Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Former Official Petitions US FDA To Stop Reviewing Russian Firms' Applications Amid Ukraine Invasion
Feb 28 2022
•
By
Derrick Gingery
Would the US consider freezing FDA reviews of applications from Russian companies? • Source: Alamy
More from Regulation
More from Policy & Regulation